- Home
- EDUC vs ATHA Comparison
EDUC vs ATHA Comparison
Compare EDUC & ATHA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EDUC
- ATHA
- Stock Information
- Founded
- EDUC 1965
- ATHA 2011
- Country
- EDUC United States
- ATHA United States
- Employees
- EDUC N/A
- ATHA N/A
- Industry
- EDUC Consumer Specialties
- ATHA Medicinal Chemicals and Botanical Products
- Sector
- EDUC Consumer Discretionary
- ATHA Health Care
- Exchange
- EDUC Nasdaq
- ATHA Nasdaq
- Market Cap
- EDUC 11.4M
- ATHA 10.6M
- IPO Year
- EDUC N/A
- ATHA 2020
- Fundamental
- Price
- EDUC $1.31
- ATHA $0.40
- Analyst Decision
- EDUC
- ATHA Buy
- Analyst Count
- EDUC 0
- ATHA 4
- Target Price
- EDUC N/A
- ATHA $11.25
- AVG Volume (30 Days)
- EDUC 5.8K
- ATHA 221.9K
- Earning Date
- EDUC 07-07-2025
- ATHA 07-31-2025
- Dividend Yield
- EDUC N/A
- ATHA N/A
- EPS Growth
- EDUC N/A
- ATHA N/A
- EPS
- EDUC N/A
- ATHA N/A
- Revenue
- EDUC $31,304,000.00
- ATHA N/A
- Revenue This Year
- EDUC N/A
- ATHA N/A
- Revenue Next Year
- EDUC N/A
- ATHA N/A
- P/E Ratio
- EDUC N/A
- ATHA N/A
- Revenue Growth
- EDUC N/A
- ATHA N/A
- 52 Week Low
- EDUC $0.92
- ATHA $0.22
- 52 Week High
- EDUC $2.49
- ATHA $3.67
- Technical
- Relative Strength Index (RSI)
- EDUC 46.26
- ATHA 67.91
- Support Level
- EDUC $1.25
- ATHA $0.29
- Resistance Level
- EDUC $1.37
- ATHA $0.39
- Average True Range (ATR)
- EDUC 0.07
- ATHA 0.03
- MACD
- EDUC -0.01
- ATHA 0.01
- Stochastic Oscillator
- EDUC 28.57
- ATHA 90.57
About EDUC Educational Development Corporation
Educational Development Corp is the United States trade publisher of the line of educational children's books produced in the United Kingdom. Its business activity functions with two reportable segments: PaperPie and Publishing. The Publishing Division segment markets its products to retail accounts, which include books, school supplies, toy and gift stores and museums, through commissioned sales representatives, trade and specialty wholesalers and an internal telesales group.
About ATHA Athira Pharma Inc.
Athira Pharma Inc is a late clinical-stage biopharmaceutical company focused on developing small molecules engineered to restore neuronal health and slow neurodegeneration. Its pipeline candidates are; Fosgonimeton (ATH-1017) is a small molecule drug candidate designed to enhance the activity of the neurotrophic hepatocyte growth factor (HGF) system; ATH-1020 a novel, orally available, next-generation small molecule drug candidate designed to positively modulate the neurotrophic HGF system; ATH-1105 is a novel, orally available, next-generation, small molecule drug candidate designed to positively modulate the neurotrophic HGF system.